Head-to-head · Value Score
Oak vs Wellorithm
Two GLP-1 deals, scored on the same six factors. Oak lands a Value Score of 88, Wellorithm a 51. Here's who gives you the honest lower price — and where each one bites back.
Oak
#5 · Grade A · Great Deal
Est. first month
$119/mo
Save ~91% vs brand-nameWellorithm
#42 · Grade C · Watch List
Est. first month
Pricing not published
The verdict
Oak takes it on Value Score, 88 to 51 — an est. $119/mo first month, with no teaser step-up baked in. Wellorithm isn't out of it: People who specifically want an oral dissolving tablet alongside brand-name pens and will complete an intake quiz before learning what any of it costs.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Oak | Wellorithm |
|---|---|---|
| Value Score | 88 (A) | 51 (C) |
| Est. first month | $119/mo | Pricing not published |
| Save vs brand-name | ~91% | — |
| Semaglutide | From $119/mo | Pricing not published |
| Tirzepatide | From $185/mo | Pricing not published |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 49 states (not Louisiana) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Oak
The cheapest published prices on the board, with genuinely flat dose pricing and nothing to cancel.
Why it's a deal
- Lowest published prices here — semaglutide from $119/mo, tirzepatide from $185/mo
- One price across every dosage, so titration never raises the bill
- No membership or subscription fee, and free shipping
- All 50 states, offered in Spanish as well as English
The fine print
- Same-day approval with no video call means very little clinical contact before a prescription
- Injection only — no oral or sublingual route, and no brand-name lane
- Sold as packages, so re-ordering is on you
Wellorithm
Four compounded routes plus four branded pens — and not one price anywhere on the public site.
Why it's a deal
- Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
- Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
- Sermorelin offered alongside the GLP-1 line
- Serves 49 states, so most of the country is covered
The fine print
- No price appears anywhere on the public site — /pricing returns 404 and every product CTA leads to an intake quiz, so no cost can be compared before signing up
- The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says it is available in 49 states and cannot provide services in Louisiana
- The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
- "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.